Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion

Human Molecular Genetics

Volumn 15, Issue 2, 2006, Pages 213-221

  Gonçalves, Manuel A F V ^a   de Vries, Antoine A F ^a   Holkers, Maarten ^a   van de Watering, Marloes J M ^a   van der Velde, Ietje ^a   van Nierop, Gijsbert P ^a   Valerio, Dinko ^a   Knaän Shanzer, Shoshan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; DYSTROPHIN; ENHANCED GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN; VIRUS VECTOR;

ARTICLE; CELL BASED GENE THERAPY; CELL FUSION; CONTROLLED STUDY; DNA MODIFICATION; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; GENETIC ENGINEERING; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM;

CELL FUSION; DYSTROPHIN; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPHENOTYPING; LENTIVIRUS; LUMINESCENT PROTEINS; MESENCHYMAL STEM CELLS; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCULAR DYSTROPHY, DUCHENNE; STEM CELL TRANSPLANTATION;

EID: 31144464491     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi438     Document Type: Article

References (29)

1. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
2. Skuk, D., Roy, B., Goulet, M., Chapdelaine, P., Bouchard, J.-P., Roy, R., Dugré, F.J., Lachance, J.-G., Deschênes, L., Senay, H., Sylvain, M. and Tremblay, J. P. (2004) Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther., 9, 475-482.
3. Cossu, G. and Sampaolesi, M. (2004) New therapies for muscular dystrophy: Cautious optimism. Trends Mol. Med., 10, 516-520.
4. Prockop, D.J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71-74.
5. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. and Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
6. Deans, R.J. and Moseley, A.B. (2000) Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol., 28, 875-884.
7. Liechty, K.W., MacKenzie, T.C., Shaaban, A.F., Radu, A., Moseley, A.B., Deans, R., Marshak, D.R. and Flake, A.W. (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med., 6, 1282-1286.
8. De Bari, C., Dell'Accio, F., Vandenabeele, F., Vermeesch, J.R., Raymackers, J.-M. and Luyten, F.P. (2003) Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol., 160, 909-918.
9. Shi, D., Reinecke, H., Murry, C.E. and Torok-Storb, B. (2004) Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood, 104, 290-294.
10. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S.-I., Ide, C. and Nabeshima, Y.-I. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309, 314-317.
11. Gonçalves, M.A.F.V., van Nierop, G.P., Tijssen, M.R., Lefesvre, P., Knaän-Shanzer, S., van der Velde, I., van Bekkum, D.W., Valerio, D. and de Vries, A.A.F. (2005) Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability. J. Virol., 79, 3146-3162.
12. Knaän-Shanzer, S., van de Watering, M.J.M., van der Velde, I., Gonçalves, M.A.F.V., Valerio, D. and de Vries, A.A.F. (2005) Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells, 23, 93-102.
13. Knaän-Shanzer, S., van der Velde, I., Havenga, M.J.E., Lemckert, A.A.C., de Vries, A.A.F. and Valerio, D. (2001) Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum. Gene Ther., 12, 1989-2005.
14. Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L. and Trono, D. (2003) Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum. Gene Ther., 14, 1525-1533.
15. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L. and Finberg, R.W. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 275, 1320-1323.
16. Tomko, R.P., Xu, R. and Philipson, L. (1997) HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl Acad. Sci. USA, 94, 3352-3356.
17. Olmsted-Davis, E.A., Gugala, Z., Gannon, F.H., Yotnda, P., McAlhany, R.E., Lindsey, R.W. and Davis, A.R. (2002) Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum. Gene Ther., 13, 1337-1347.
18. Grove, J.E., Bruscia, E. and Krause, D.S. (2004) Plasticity of bone marrow-derived stem cells. Stem Cells, 22, 487-500.
19. Wang, G., Bunnell, B.A., Painter, R.G., Quiniones, B.C., Tom, S., Lanson, N.A., Jr, Spees, J.L., Bertucci, D., Peister, A., Weiss, D.J. et al. (2005) Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis. Proc. Natl Acad. Sci. USA, 102, 186-191.
20. Nudel, U., Zuk, D., Zeelon, E., Levy, Z., Neuman, S. and Yaffe, D. (1989) Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature, 337, 76-78.
21. Lapidos, K.A., Chen, Y.E., Earley, J.U., Heydemann, A., Huber, J.M., Chien, M., Ma, A. and McNally, E.M. (2004) Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J. Clin. Invest., 114, 1577-1585.
22. Rodriguez, A.-M., Pisani, D., Dechesne, C.A., Turc-Carel, C., Kurzenne, J.-Y., Wdziekonski, B., Villageois, A., Bagnis, C., Breittmayer, J.-P., Groux, H. et al. (2005) Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med., 201, 1397-1405.
23. van Tuyn, J., Knaän-Shanzer, S., van de Watering, M.J.M., de Graaf, M., van der Laarse, A., Schalij, M.J., van der Wall, E.E., de Vries, A.A.F. and Atsma, D.E. (2005) Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc. Res., 67, 245-255.
24. Anson, D.S. and Fuller, M. (2003) Rational development of a HIV-1 gene therapy vector. J. Gene Med., 5, 829-838.
25. Bevis, B.J. and Glick, B.S. (2002) Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat. Biotechnol., 20, 83-87.
26. Seppen, J., Rijnberg, M., Cooreman, M.P. and Oude Elferink, R.P.J. (2002) Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J. Hepatol., 36, 459-465.
27. Chapdelaine, P., Moisset, P.-A., Campeau, P., Asselin, I., Vilquin, J.-T. and Tremblay, J. P. (2000) Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng., 13, 611-615.
28. Gonçalves, M.A.F.V., van der Velde, I., Janssen, J.M., Maassen, B.T.H., Heemskerk, E.H., Opstelten, D.-J.E., Knaän-Shanzer, S., Valerie, D. and de Vries, A.A.F. (2002) Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. J. Virol., 76, 10734-10744.
29. Nenoi, M., Mita, K., Ichimura, S., Cartwright, I.L., Takahashi, E.-I., Yamauchi, M. and Tsuji, H. (1996) Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3 cells. Gene, 175, 179-185.